Article
Novel loci interacting epistatically with bone morphogenetic protein receptor 2 cause familial pulmonary arterial hypertension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation - 1 Feb 2010
Rodriguez-Murillo Laura, Subaran Ryan, Stewart William C L, Pramanik Sreemanta, Marathe Sudhir, Barst Robyn J, Chung Wendy K, Greenberg David A
Abstract excerpt
BACKGROUND: Familial pulmonary arterial hypertension (FPAH) is a rare, autosomal-dominant, inherited disease with low penetrance. Mutations in the bone morphogenetic protein receptor 2 (BMPR2) have been identified in at least 70% of FPAH patients. However, the lifetime penetrance of these BMPR2 mutations is 10% to 20%, suggesting that genetic and/or environmental modifiers are required for disease expression. Our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
